HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.

Abstract
The non-structural 3 (NS3) protein is one of the most conserved proteins of hepatitis C virus, and T helper 1 (Th1)-like responses to NS3 in humans correlate with clearance of infection. Several studies have proposed that DNA-based immunizations are highly immunogenic and prime Th1-like responses, although few head-to-head comparisons with exogenous protein immunizations have been described. A full-length NS3/NS4A gene was cloned in eukaryotic vectors with expression directed to different subcellular compartments. Inbred mice were immunized twice in regenerating tibialis anterior (TA) muscles with either plasmid DNA or recombinant NS3 (rNS3). After two 100 micrograms DNA immunizations, specific antibody titres of up to 12960 were detected at week 5, dominated by IgG2a and IgG2b. NS3-specific CD4(+) T cell responses in DNA-immunized mice peaked at day 13, as measured by proliferation and IL-2 and IFN-gamma production. Mice immunized with 1-10 micrograms rNS3 without adjuvant developed antibody titres comparable to those of the DNA-immunized mice, but dominated instead by IgG1. CD4(+) T cell responses in these mice showed peaks of IL-2 response at day 3 and IL-6 and IFN-gamma responses at day 6. With adjuvant, rNS3 was around 10-fold more immunogenic with respect to speed and magnitude of the immune responses. Thus, immunization with rNS3 in adjuvant is superior to DNA immunization with respect to kinetics and quantity in priming specific antibodies and CD4(+) T cells. However, as a DNA immunogen, NS3 elicits stronger Th1-like immune responses, whereas rNS3 primes a mixed Th1/Th2-like response regardless of the route, dose or adjuvant.
AuthorsUna Lazdina, Catharina Hultgren, Lars Frelin, Margaret Chen, Karin Lodin, Ola Weiland, Geert Leroux-Roels, Juan A Quiroga, Darrell L Peterson, David R Milich, Matti Sällberg
JournalThe Journal of general virology (J Gen Virol) Vol. 82 Issue Pt 6 Pg. 1299-1308 (Jun 2001) ISSN: 0022-1317 [Print] England
PMID11369873 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Cytokines
  • Hepatitis C Antibodies
  • Hepatitis C Antigens
  • Immunoglobulin G
  • NS3 protein, hepatitis C virus
  • Recombinant Proteins
  • Vaccines, DNA
  • Viral Hepatitis Vaccines
  • Viral Nonstructural Proteins
Topics
  • Adjuvants, Immunologic
  • Animals
  • Cytokines (biosynthesis, immunology)
  • Genetic Vectors (genetics)
  • Hepacivirus (genetics, immunology)
  • Hepatitis C Antibodies (biosynthesis, immunology)
  • Hepatitis C Antigens (genetics, immunology)
  • Immunoglobulin G (biosynthesis, immunology)
  • Kinetics
  • Lymph Nodes (immunology)
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred Strains
  • Recombinant Proteins (genetics, immunology)
  • Spleen (immunology)
  • Th1 Cells (immunology)
  • Vaccination
  • Vaccines, DNA (administration & dosage, genetics, immunology)
  • Viral Hepatitis Vaccines (administration & dosage, genetics, immunology)
  • Viral Nonstructural Proteins (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: